Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

775
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
775
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

239
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
239
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

204
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
204
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

288
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
288
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

400
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
400
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

371
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
371

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postmyocardial Infarction Depression as a Modifiable Secondary Prevention Risk Factor.

Cardiology in review·2026
Same author

Coronary Artery Calcium as a Biological Staging Marker for Atherosclerosis: Aligning Preventive Therapies With Plaque Evolution.

Cardiology in review·2026
Same author

Albuminuria in Heart Failure: From Marker to Modifiable Target.

Cardiology in review·2025
Same author

High-Density Lipoprotein Dysfunction and Atherosclerotic Cardiovascular Disease: From Quantity to Quality.

Cardiology in review·2025
Same author

Coenzyme Q10 in Heart Failure: Mechanisms and Therapeutic Potential.

Cardiology in review·2025
Same author

Survodutide: A Dual GLP-1/Glucagon Agonist Reshaping Cardiometabolic Care.

Cardiology in review·2025

Related Experiment Video

Updated: Jan 10, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.7K

Beyond Diursesis: Rethinking Fluid and Sodium Strategies in Heart Failure.

Amogh Jyothi Arun1, Madiha Baig1, Bhavika Darji1

  • 1From the School of Medicine, New York Medical College, Tarrytown, NY.

Cardiology in Review
|November 26, 2025
PubMed
Summary

Fluid and sodium management in heart failure (HF) is evolving. Recent evidence suggests liberal fluid intake and moderate sodium restriction are safe and improve quality of life, challenging traditional restrictive practices.

Keywords:
chronic managementdecongestionfluid managementheart failuresodium restriction

More Related Videos

Evaluation of Fluid Overload by Bioelectrical Impedance Vectorial Analysis
07:17

Evaluation of Fluid Overload by Bioelectrical Impedance Vectorial Analysis

Published on: August 17, 2022

3.2K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.1K

Related Experiment Videos

Last Updated: Jan 10, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.7K
Evaluation of Fluid Overload by Bioelectrical Impedance Vectorial Analysis
07:17

Evaluation of Fluid Overload by Bioelectrical Impedance Vectorial Analysis

Published on: August 17, 2022

3.2K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.1K

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Heart failure (HF) poses a significant global health challenge, characterized by high morbidity, mortality, and healthcare costs, largely due to recurrent hospitalizations.
  • Fluid and sodium management are critical yet inconsistently standardized aspects of HF care, with traditional restrictive approaches increasingly being re-evaluated.
  • Advances in guideline-directed therapy have been substantial, but optimizing fluid and sodium balance remains a key area for improvement.

Purpose of the Study:

  • To review current evidence and refine strategies for fluid and sodium management in heart failure (HF).
  • To evaluate the efficacy and safety of different diuretic strategies, ultrafiltration, and subcutaneous furosemide in acute HF.
  • To assess the impact of fluid and sodium restriction versus liberal intake on outcomes and quality of life in outpatient HF management.

Main Methods:

  • Review of contemporary evidence from key clinical trials, including ADVOR, DOSE, FRESH-UP, and SODIUM-HF.
  • Analysis of acute HF management strategies focusing on loop diuretics, sequential nephron blockade, ultrafiltration, and subcutaneous furosemide.
  • Evaluation of outpatient strategies involving fluid intake (liberal vs. restricted) and sodium intake (aggressive restriction vs. moderate restriction).

Main Results:

  • In acute HF, loop diuretics are essential, with strategies like early titration and sequential nephron blockade optimizing decongestion and renal function. Ultrafiltration is reserved for refractory cases.
  • Subcutaneous furosemide shows promise for outpatient parenteral diuresis, improving decongestion and dyspnea, potentially reducing hospitalizations.
  • Outpatient studies (FRESH-UP, SODIUM-HF) indicate that routine liberal fluid intake guided by thirst and moderate sodium restriction are safe and improve quality of life, contrary to aggressive restriction.

Conclusions:

  • Current evidence supports a shift away from rigid fluid and sodium restrictions in heart failure management.
  • Individualized, patient-centered approaches prioritizing quality of life, guided by thirst and moderate sodium intake, are recommended.
  • Future advancements may involve objective monitoring tools (lung ultrasound, bioimpedance) and AI-driven models for precision fluid and sodium management in HF.